Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

AI investor favorite Nvidia is trading at record high levels and is now the world's most valuable company by market capitalization. Here are important chart levels to monitor.

AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

AbbVie stock drops after Phase 2 trials of emraclidine fail to meet primary endpoint. The company continues data analysis for ...

Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.

Aurinia (AUPH) stock jumped 14% Thursday after the company reported better-than-expected Q3 revenue and announced it was ...

On Halloween, Altria Group ( MO 0.33%) released its latest set of quarterly figures. The results weren't scary at all -- in fact, a great many investors found them encouraging, and the cigarette maker ...

Altria's NJOY business was the driver of its Q3 results, with consumable shipments jumping 15.6% to 10.4 million units. NJOY device shipments, meanwhile, more than doubled to 1.1 million units. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...